Your session is about to expire
← Back to Search
CBT for Autism Spectrum Disorder (BIACA-2 Trial)
Phase 1 & 2
Waitlist Available
Led By Jeffrey Wood, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months (post-treatment)
Awards & highlights
BIACA-2 Trial Summary
This study is designed to examine the efficacy of a cognitive behavioral therapy (CBT) program for treating core autism symptoms, social and emotional problems, and adaptive behavior deficits in children with autism spectrum disorders.
Eligible Conditions
- Autism Spectrum Disorder
- Autism
BIACA-2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 months (post-treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months (post-treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ADIS-C/P (Anxiety Disorder Interview Schedule for Children and Parents)
Secondary outcome measures
Behavioral observations of social responsiveness
Side effects data
From 2015 Phase 2 trial • 142 Patients • NCT0096488629%
dry mouth
24%
constipation
24%
difficulty urinating
18%
erectile dysfunction
12%
ejaculatory dysfunction
12%
accomodation disturbance
12%
orgasm dysfunction
6%
decreased libido
6%
increased dreaming
6%
muscle rigidity
6%
photosensitivity
6%
insomnia
6%
diaphoresis
3%
urosepsis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm 1
Arm 3
Arm 2
Arm 4
BIACA-2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CBTExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cognitive behavioral therapy
2010
Completed Phase 2
~930
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,537 Previous Clinical Trials
10,266,951 Total Patients Enrolled
25 Trials studying Autism Spectrum Disorder
4,379 Patients Enrolled for Autism Spectrum Disorder
Organization for Autism ResearchOTHER
6 Previous Clinical Trials
131 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
69 Patients Enrolled for Autism Spectrum Disorder
Jeffrey Wood, PhDPrincipal InvestigatorUniversity of California, Los Angeles
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger